Our partners at PYA have released a new white paper explaining how competing health systems may overcome antitrust obstacles to merger by formally committing to population health improvement in the communities they serve.
PYA, a national healthcare consulting and professional services firm, has released a white paper, “Overcoming Antitrust Obstacles to Mergers by Committing to Population Health Improvement.” The white paper discusses the challenges antitrust laws can create for healthcare providers contemplating consolidation; explores the pro-competitive benefits of consolidation when the new entity commits to population health; and explains how providers may pursue Certificates of Public Advantage and similar state programs to eliminate federal antitrust concerns.
In one such case, the white paper notes, “[t]hrough a three-year process, [the merged providers] were able to demonstrate that consolidation, not continued competition, is in the best interests of the communities they serve. The investments [the newly consolidated entity] has committed to make would not be possible if the inefficiencies of operating two separate organizations had continued.”
This white paper is derived from a PYA article originally published in the AHLA Transactions Guide. The Guide features up-to-date information and legal news and analysis for healthcare attorneys.
With extensive experience in mergers and acquisitions and other healthcare transactions, PYA’s cross-functional teams partner with clients and legal counsel in all 50 states to craft solutions that create the greatest value from business combinations. Founded in 1983, PYA leverages a deep industry knowledge base and dedicated, healthcare-savvy professionals to provide expertise throughout the full cycle of the transaction.
The post PYA White Paper Explains How Pro-Competitive Impacts of Hospital Consolidation Can Overcome Antitrust Concerns appeared first on PYA.